Literature DB >> 7568556

Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia.

M L Rao1, B Strebel, A Halaris, G Gross, P Bräunig, G Huber, M Marler.   

Abstract

Changes in the circadian rhythmicity in vital signs, catecholamines, thyroid hormones, and cortisol have been observed in psychiatric disorders, most notably in depression. With respect to schizophrenia, the literature is scanty. We report here on the circadian parameter estimates of the vital signs, epinephrine, norepinephrine, triiodothyronine, thyroxine, thyroid stimulating hormone, and cortisol in the blood of 34 healthy subjects, 89 drug-free schizophrenic patients, and 25 neuroleptic-treated schizophrenic patients. The analyses are based on the cosine model to fit the experimental data. The circadian profiles of heart rate, blood pressure, and oral temperature are similar among schizophrenic patients and healthy subjects. Neuroleptic-treated patients have significantly higher MESORs (the daily mean) of serum norepinephrine and epinephrine than healthy subjects. The TSH MESOR is significantly lower in schizophrenic patients; the MESOR of triiodothyronine also shows a tendency to be nonsignificantly lower in schizophrenic patients compared with control subjects. The circadian serum thyroxine and cortisol profiles are similar in the three groups. The data show that the circadian profiles of vital signs in drug-free chronic schizophrenic patients who are not chronically hospitalized are similar to those of healthy subjects and that the increase in serum catecholamines and the apparent lowering in some thyroid indices might induce a down-regulation in the noradrenergic receptor system that could contribute to the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568556     DOI: 10.1016/0165-1781(95)02525-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

Review 1.  A new look at the neural diathesis--stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations.

Authors:  Simon R Jones; Charles Fernyhough
Journal:  Schizophr Bull       Date:  2006-11-14       Impact factor: 9.306

2.  Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis.

Authors:  Janine A E M van Venrooij; Sjoerd B A H A Fluitman; Jeroen G Lijmer; Annemieke Kavelaars; Cobi J Heijnen; Herman G M Westenberg; René S Kahn; Christine C Gispen-de Wied
Journal:  Schizophr Bull       Date:  2010-06-17       Impact factor: 9.306

3.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

Review 4.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Revisiting thyroid hormones in schizophrenia.

Authors:  Nadine Correia Santos; Patrício Costa; Dina Ruano; António Macedo; Maria João Soares; José Valente; Ana Telma Pereira; Maria Helena Azevedo; Joana Almeida Palha
Journal:  J Thyroid Res       Date:  2012-03-26

6.  Levothyroxine Augmentation in Clozapine Resistant Schizophrenia: A Case Report and Review.

Authors:  Ruohollah Seddigh; Somayeh Azarnik; Amir-Abbas Keshavarz-Akhlaghi
Journal:  Case Rep Psychiatry       Date:  2015-05-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.